Gaw A, Packard C J, Lindsay G M, Griffin B A, Caslake M J, Lorimer A R, Shepherd J
Institute of Biochemistry, Glasgow Royal Infirmary, UK.
J Lipid Res. 1995 Jan;36(1):158-71.
An analysis of apolipoprotein (apo) B turnovers conducted in subjects with moderate hypercholesterolemia was performed to discover relationships that may exist between apoB kinetic parameters and plasma lipid and lipoprotein levels. A group of 21 subjects with plasma cholesterol in the range 250-300 mg/dl and triglyceride < 265 mg/dl were injected with tracers of 131I-labeled very low density lipoprotein 1 (VLDL1, Sf 60-400) and 125I-labeled VLDL2 (Sf 20-60) prepared by cumulative flotation ultracentrifugation. The metabolism of apoB in these fractions was followed through intermediate density (IDL, Sf 12-20) to low density (LDL, Sf 0-12) lipoprotein. The most consistent feature giving rise to the higher apoB levels that occurred in VLDL2, IDL, and LDL in the hypercholesterolemic group was increased input of VLDL2 (787 +/- 607 (SD) mg/day vs. 349 +/- 213 in normals, P < 0.01). VLDL1 apoB input was variably affected and not significantly different from normal. However, the plasma residence time of this subfraction was increased (0.15 +/- 0.07 days vs. 0.08 +/- 0.03 days in normals, (P < 0.001) due to a decreased fractional rate of direct catabolism. Fractional transfer rates (FTR) down the delipidation cascade and other fractional rates of direct catabolism were, overall, not significantly different from normal. The plasma residence time of VLDL2 apoB and LDL apoB was similar in hypercholesterolemic and normal subjects, while that of IDL apoB was slightly increased. Variation in LDL apoB mass within the hypercholesterolemic group correlated with VLDL1 apoB input (r = 0.58, P = 0.006), the fractional rate of transfer from IDL to LDL (r = 0.61, P = 0.003), and direct LDL input (r = 0.64, P = 0.002). The proportion of LDL apoB mass derived by direct, i.e., VLDL-independent input, varied from 5 to 50% and was inversely correlated with plasma triglyceride (r = -0.53, P = 0.014) and positively with HDL2 (r = 0.66, P = 0.002). In addition, the amount of direct LDL input was related to the amount of VLDL1 removed by direct catabolism (r = 0.53, P = 0.013). The analysis indicated that moderate hypercholesterolemia arose principally from overproduction of small VLDL, while variation in VLDL1 input and the IDL to LDL conversion rate (presumably hepatic lipase-mediated) modulated the extent of the elevation in LDL apoB.
对中度高胆固醇血症患者的载脂蛋白(apo)B周转率进行了分析,以发现apoB动力学参数与血浆脂质和脂蛋白水平之间可能存在的关系。选取了21名血浆胆固醇在250 - 300mg/dl范围内且甘油三酯<265mg/dl的受试者,给他们注射通过累积浮选超速离心法制备的131I标记的极低密度脂蛋白1(VLDL1,Sf 60 - 400)和125I标记的VLDL2(Sf 20 - 60)示踪剂。通过中间密度脂蛋白(IDL,Sf 12 - 20)至低密度脂蛋白(LDL,Sf 0 - 12)来追踪这些组分中apoB的代谢情况。导致高胆固醇血症组VLDL2、IDL和LDL中apoB水平升高的最一致特征是VLDL2的输入增加(787±607(标准差)mg/天,而正常人为349±213,P<0.01)。VLDL1 apoB的输入受到不同程度影响,与正常情况无显著差异。然而,由于直接分解代谢的分数率降低,该亚组分的血浆停留时间增加(0.15±0.07天,而正常人为0.08±0.03天,P<0.001)。总体而言,沿脱脂级联反应的分数转移率(FTR)和其他直接分解代谢的分数率与正常情况无显著差异。高胆固醇血症患者和正常受试者中VLDL2 apoB和LDL apoB的血浆停留时间相似,而IDL apoB的血浆停留时间略有增加。高胆固醇血症组中LDL apoB质量的变化与VLDL1 apoB输入相关(r = 0.58,P = 0.006),从IDL向LDL的转移分数率相关(r = 0.61,P = 0.003),以及直接LDL输入相关(r = 0.64,P = 0.002)。直接即不依赖VLDL的输入所产生的LDL apoB质量比例在5%至50%之间变化,且与血浆甘油三酯呈负相关(r = -0.53,P = 0.014),与HDL2呈正相关(r = 0.66,P = 0.002)。此外,直接LDL输入量与通过直接分解代谢清除的VLDL1量相关(r = 0.53,P = 0.013)。分析表明,中度高胆固醇血症主要源于小VLDL的过量产生,而VLDL1输入的变化以及IDL向LDL的转化率(可能由肝脂酶介导)调节了LDL apoB升高的程度。